The VJ Sessions aim to bring together leading experts in the oncology community to support international collaboration and allow them to discuss what the latest advances in diagnosis & therapy actually mean in the clinic.
View our growing collection of on-demand roundtable discussions across a range of oncology specialties below or listen to the podcasts on the go.
Lung Cancer
How to interpret ctDNA reports
EGFR Exon 20 insertions - identifying and managing patients in the UK
Highlights in Lung Cancer from WCLC 2022 with Lizza Hendriks & Tiziana Vavalà
Highlights in Lung Cancer from ASCO 2022 with Jia Luo and Julia Rotow
BTOG 2022 UK panel discussion
Topics: The current state of UK lung cancer care, novel IO targets & therapeutic cancer vaccines and the deployment of genomic testing in the UK
EGFR-mutated NSCLC
Topics: Latest advances in EGFR-mutated NSCLC care including considerations around EGFR testing, first-line treatment options, immunotherapy, management of brain metastases, surveillance on therapy, reprofiling, the latest clinical trial data and what is on the horizon.
ESMO & WCLC 2021
Topics: Lung cancer screening in the UK, adjuvant radiotherapy, concomitant chemo-radiation, resected NSCLC data, molecular testing, POSEIDON & HER2-mutated NSCLC
ASCO 2021
BTOG 2021
IASLC WCLC 2020
ESMO 2020
Breast Cancer
Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons
Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja
Topics: TROPiCS-02, MONARCH-3, DATA, SYNERGY and BELLINI.
Examining DESTINY-Breast04 with Matteo Lambertini & Evandro de Azambuja
Latest updates from ASCO 2022 with Paolo Tarantino & Romualdo Barroso
Updates in TNBC with Roberto Salgado & Marleen Kok
Topics: Treatment de-escalation, biomarkers and TILs
Highlights from SABCS 2021 with Hope Rugo & Dave Cescon
Topics: KEYNOTE-522, KEYNOTE-355; EMERALD, and more IO updates at SABCS
Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
Topics: KEYNOTE-522, KEYNOTE-355; NIMBUS, and more IO updates at SABCS
Immunotherapy updates at SABCS 2021
Topics: KEYNOTE-522, KEYNOTE-355; NIMBUS, and more IO updates at SABCS
ESMO 2021
ASCO 2021
Topics: OlympiA & olaparib, capecitabine, GeparNuevo & BEGONIA, CDK4/6, SERDs, BCL-2 & talazoparib
St. Gallen Consensus 2021
Topics: pCR & IO, carboplatin & olaparib, gene signature assays & CDK4/6 inhibitors
SABCS 2020
Topics: CDK4/6 inhibitors, RxPONDER & premenopausal pts, IO and more SABCS highlights
GU Cancers
Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala
Topics: RADICALS-HD, FORMULA-509, and adaptive radiotherapy
Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff
Topics: TRITON3, TALAPRO-2, TROPHY-U-01, COSMIC-313, & CheckMate 9ER
ASCO GU Cancers Symposium 2022
Topics: PROpel, MAGNITUDE & ARASENS in prostate cancer and NEOAVAX, KN-564 and axitinib plus nivo in renal cell carcinoma
Prostate updates from ESMO 2021
Topics: Combined analysis from STAMPEDE, OS results from PEACE-1 & results from cohort 6 of COSMIC-021
Bladder updates at ESMO 2021
Bladder & Kidney at ASCO 2021
Bladder & Kidney at ASCO GU Cancers Symposium 2021
Prostate Cancer at ASCO GU Cancers Symposium 2021
GI Cancers
Highlights from ESMO 2022 with Geoffrey Ku and Sam Klempner
ASCO GI Cancers Symposium 2022
Topics: TOPAZ-1 in biliary tract cancer, HIMALAYA & KRYSTAL-1, CIRCULATE-Japan & incorporating ctDNA in the clinic, ACCENT/IDEA & PD-1 blockade in MSI-high rectal cancer.
Upper GI updates from ESMO 2021
Topics: CheckMate 649, DESTINY-Gastric02, MAHOGANY & chemo in HER2+ gastric cancer, CLDN 18.2-targeted CAR-T, KRYSTAL-1 in CRC, PRODIGE 24 in PDAC & more
